Literature DB >> 33021569

Lymphocyte Immunosuppression and Dysfunction Contributing to Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS).

Christian B Bergmann1, Nadine Beckmann1, Christen E Salyer1, Peter A Crisologo2, Vanessa Nomellini1,3, Charles C Caldwell1,4.   

Abstract

ABSTRACT: Persistent Inflammation, Immune Suppression, and Catabolism Syndrome (PICS) is a disease state affecting patients who have a prolonged recovery after the acute phase of a large inflammatory insult. Trauma and sepsis are two pathologies after which such an insult evolves. In this review, we will focus on the key clinical determinants of PICS: Immunosuppression and cellular dysfunction. Currently, relevant immunosuppressive functions have been attributed to both innate and adaptive immune cells. However, there are significant gaps in our knowledge, as for trauma and sepsis the immunosuppressive functions of these cells have mostly been described in acute phase of inflammation so far, and their clinical relevance for the development of prolonged immunosuppression is mostly unknown. It is suggested that the initial immune imbalance determines the development of PCIS. Additionally, it remains unclear what distinguishes the onset of immune dysfunction in trauma and sepsis and how this drives immunosuppression in these cells. In this review, we will discuss how regulatory T cells (Tregs), innate lymphoid cells, natural killer T cells (NKT cells), TCR-a CD4- CD8- double-negative T cells (DN T cells), and B cells can contribute to the development of post-traumatic and septic immunosuppression. Altogether, we seek to fill a gap in the understanding of the contribution of lymphocyte immunosuppression and dysfunction to the development of chronic immune disbalance. Further, we will provide an overview of promising diagnostic and therapeutic interventions, whose potential to overcome the detrimental immunosuppression after trauma and sepsis is currently being tested.
Copyright © 2020 by the Shock Society.

Entities:  

Mesh:

Year:  2021        PMID: 33021569     DOI: 10.1097/SHK.0000000000001675

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  DDX3X mRNA Expression in T Cells Is Associated with the Severity and Mortality of Septic Patients.

Authors:  Yukun Liu; Yongsheng Zhang; Qinxin Liu; Weiming Xie; Xiang Wang; Fan Yang; Wei Gao; Xiangjun Bai; Zhanfei Li; Yuchang Wang
Journal:  Dis Markers       Date:  2022-02-08       Impact factor: 3.434

2.  Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome.

Authors:  Jovana Milic; Sara Barbieri; Licia Gozzi; Alberto Brigo; Bianca Beghé; Alessia Verduri; Erica Bacca; Vittorio Iadisernia; Gianluca Cuomo; Giovanni Dolci; Dina Yaacoub; Emanuele Aprile; Michela Belli; Maria Venuta; Marianna Meschiari; Giada Sebastiani; Enrico Clini; Cristina Mussini; Amedeo Lonardo; Giovanni Guaraldi; Paolo Raggi
Journal:  Open Forum Infect Dis       Date:  2022-01-10       Impact factor: 3.835

3.  Lymphocyte trajectories are associated with prognosis in critically ill patients: A convenient way to monitor immune status.

Authors:  Fei Pei; Wenliang Song; Luhao Wang; Liqun Liang; Bin Gu; Minying Chen; Yao Nie; Yishan Liu; Yu Zhou; Xiangdong Guan; Jianfeng Wu
Journal:  Front Med (Lausanne)       Date:  2022-08-04

Review 4.  The immunomodulatory function of adenosine in sepsis.

Authors:  Teng Zhang; Li Yu-Jing; Tao Ma
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

5.  Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model.

Authors:  Yukun Liu; Kang Wang; Qaunrui Feng; Yongsheng Zhang; Chuntao Wang; Qinxin Liu; Xinghua Liu; Xiang Wang; Wei Gao; Xiangjun Bai; Zhanfei Li; Yuchang Wang
Journal:  J Immunol Res       Date:  2021-07-05       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.